Skip to content

Difference analysis of electromyography biofeedback therapy for foot ptosis in convalescent stroke patients with different stimulation sites and directions

Difference analysis of electromyography biofeedback therapy for foot ptosis in convalescent stroke patients with different stimulation sites and directions

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100049209
Enrollment
Unknown
Registered
2021-07-25
Start date
2021-08-01
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

Group1:Two surface electrodes were attached to the triceps muscle abdomen of the leg to guide the patient to do ankle dorsiflexion
Group2:Two surface electrodes were attached to the anterior tibialis muscle abdomen to guide the patient to do ankle dorsiflexion
Group3:Two surface electrodes were placed on the abdomens of long and short peroneal muscles to guide patients to perform ankle dorsiflexion and valgus

Sponsors

The First Affiliated Hospital of Bengbu Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. In line with the ''Key Points for Diagnosis of Various Cerebrovascular Diseases'' adopted by the 4th National Cerebrovascular Disease Academic Conference in 1995, and confirmed by head imaging CT or MRI; 2. Has definite hemiplegia on one side, and is accompanied by foot drop and (or) foot inversion; 3. The first onset or a history of stroke but no obvious sequelae; 4. Comply with the Chinese Stroke Rehabilitation Treatment Guidelines; 5. The assessment by the Simple Mental State Scale is basically normal, and aged 35 to 75 years; 6. Voluntarily participate in this experiment and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. The onset is within 2 weeks, and the symptoms are unstable; 2. The blood pressure is still higher than 180/100mmHg (1mmHg=0.133kPa), or the blood pressure fluctuates repeatedly recently; 3. The amount of hemorrhage in the basal ganglia or cerebral lobe is more than 30ml, or hemorrhage in the brainstem and cerebellum; 4. Combined with severe heart, liver and renal insufficiency; 5. Combined with myogenic diseases and peripheral nervous system diseases; 6. Difficulty in understanding or cognitive impairment.

Design outcomes

Primary

MeasureTime frame
EMG integral value;Fugl-Meyer sports score;Activity of daily life;Berg balance scale;Improved Ashworth muscle tension grading standard;Manual muscle strength test scoring standard;Active joint range of motion;

Countries

China

Contacts

Public ContactLi Lin

Bengbu Medical College

269610320@qq.com+86 19810753987

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026